BD4677841
Cefadroxil , 98% , 50370-12-2
CAS NO.：50370-12-2
Empirical Formula: C16H17N3O5S
Molecular Weight: 363.39
MDL number: MFCD00865091
EINECS: 256-555-6
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB130.40 | In Stock |
|
| 250mg | RMB213.60 | In Stock |
|
| 1g | RMB567.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 197°C (rough estimate) |
| Boiling point: | 238°C (rough estimate) |
| Density | 1.59 |
| refractive index | 1.6390 (estimate) |
| storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C |
| solubility | Water:9.17(Max Conc. mg/mL);25.23(Max Conc. mM) |
| pka | 3.12±0.50(Predicted) |
| form | powder or crystals |
| color | White to off-white |
| InChIKey | BOEGTKLJZSQCCD-UEKVPHQBSA-N |
Description and Uses
Cephadroxil is an orally administered antibiotic, which is very similar to cephalexin. After oral administration, its peak serum level is slightly lower than that of cephalexin, but it is excreted more slowly. Therefore, it can be used for oral administration at 8- or 12-hourly intervals (Buck and Price, 1977; Pfeffer et al., 1977). Cephadroxil is still available in a number of European countries (for example, Spain, Belgium, Luxembourg, Portugal, and Finland, among others).
Antibacterial;Bacterial transpeptidase inhibitor
Safety
| Symbol(GHS) |   GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H315-H317-H319-H334-H335 |
| Precautionary statements | P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xn |
| Risk Statements | 36/37/38-42/43 |
| Safety Statements | 26-36 |
| WGK Germany | 2 |
| RTECS | XI0337000 |
